Emerging Vision, Inc. (fka ISEE)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

ClayTrader Free

11/20/19 4:09 PM

Post #75

* * $ISEE Video Chart 11-20-19 * *

Link to Video - click here to watch the technical chart video

swampboots PremiumMember

11/01/19 2:33 PM

Post #74

Re: #73: @deadjim - 3.70s. Killer.. had me concerned for a bit

4.25 chartist control this actual likely failed drug, as fumes from endpoint data reflect odds of probable failure.

deadjim

11/01/19 12:03 PM

Post #73

3.70s. Killer.. had me concerned for a bit

deadjim

11/01/19 10:42 AM

Post #72

3.50s holy shiiiiiiiiiiiii.. She gonna hold this time??

deadjim

10/31/19 12:28 PM

Post #71

Pushing through 3.40s.. amazing. Let’s see it smash highs

swampboots PremiumMember

10/31/19 12:17 PM

Post #70

Re: #69: @DewDiligence - …miraculously, it works here. I would respectfully disagre

Dew is so correct, I dislike the false impressions unchallenged by many sites which carried that misleading PR.

DewDiligence PremiumMember

10/31/19 11:35 AM

Post #69

Re: #65: @swampboots - OPHT was earlier name when 2 drugs

…miraculously, it works here.

I would respectfully disagree—please see #msg-152020152.

deadjim

10/31/19 10:07 AM

Post #68

Re: #67: @deadjim - would like to see a push through 3.30s,

if fill gap then nhods and 4s break coming..less go

deadjim

10/31/19 10:05 AM

Post #67

would like to see a push through 3.30s, oh snap there it goes as i type

deadjim

10/31/19 9:42 AM

Post #66

There’s the low IF shes zooming back up today

swampboots PremiumMember

10/31/19 9:22 AM

Post #65

Re: #63: @deadjim - For example I see now this is OPHT

OPHT was earlier name when 2 drugs had total failure, new drug was repurposed from wet macular degeneration to dry type...miraculously it works here.

deadjim

10/31/19 7:14 AM

Post #64

Well there’s 4 even if I couldn’t sell it.. thinking morning dip and rip

deadjim

10/30/19 8:06 PM

Post #63

Re: #61: @swampboots - Only few times a decade do I take

For example I see now this is OPHT — I remember the symbol. Still not familiar with the company though. Lol

deadjim

10/30/19 7:35 PM

Post #62

Re: #61: @swampboots - Only few times a decade do I take

I generally hate ihub, and I can’t really use other opinions but my own but I enjoy discussion. I honestly just know very little. I still have to go back and see why this gapped down, and what the market cap was back then. I’d have to check market gap at the top of base and bottom.. these splits get tricky especially on big pops like this. Just gotta ride it as long as it stays ahead of your position

swampboots PremiumMember

10/30/19 7:31 PM

Post #61

Re: #60: @deadjim - I don’t know anything about that. I don’t

Only few times a decade do I take off my boots and pander to the public to offer sure shot victory laps before the race, but you can see I was only one on IHUB who moved the needle with non chart DD and went over the top promoting , which is not my DNA on IHUB.
So best you can o this end, is now is hope I find another in next 10 years to oracle some nice tidy profit.

deadjim

10/30/19 7:26 PM

Post #60

Re: #59: @swampboots - ISEE true market cap rose from 40 million

I don’t know anything about that. I don’t disagree, but All i see is a biotech that did a reverse split, has low OS with news, and a loonnnnggg collapse period from a gap that happened years ago. I’d have to do too much digging to figure this one out. I like their cash position, but I appreciate any discussion on company direction and history. Hopefully I can continue to nail the trade here, it’ll get harder shortly

swampboots PremiumMember

10/30/19 7:23 PM

Post #59

Re: #57: @deadjim - Thinkin 4s outta gate and sit back a

ISEE true market cap rose from 40 million to almost 140 million, but the drugs for the wet version by Lucentis garner over a billion in revenues and only 15% of macular degeneration population, as opposed to this DRY version application comprising 90% of that population. And from my observations with limited parties as a non-medical person, the endpoint bar is very low for this unmet remedy for this nasty disease.
Inveric just have to peddle this statistical significance into final approval or merge with their betters to endure eons of royalties.
I see more kisses after some conferences shinning lights and (to be frank)media momentum by reporters imbued with creating startling over the top sensational headlines.

swampboots PremiumMember

10/30/19 7:21 PM

Post #58

Re: #57: @deadjim - Thinkin 4s outta gate and sit back a

deadjim

10/30/19 7:06 PM

Post #57

Re: #56: @swampboots - ISEE make that an even 3.80 right

Thinkin 4s outta gate and sit back a little.. I sold half of my position so hope the rest doesn’t slam me

swampboots PremiumMember

10/30/19 7:05 PM

Post #56

Re: #55: @deadjim - new hires = new highs.3.79 ohhhh daaamn

ISEE make that an even 3.80 right this minute.

deadjim

10/30/19 4:17 PM

Post #55

Re: #46: @deadjim - There’s the .90s test... If it retest it

new hires = new highs.3.79 ohhhh daaamn

swampboots PremiumMember

10/30/19 3:59 PM

Post #54

Re: #42: @swampboots - ISEE 3.03 just keeping track to measure my

ISEE 3.60, cash plus, only remedy for 15 million, no incentive to short ++$$$$$$$$$$.different bird comes every 5 years or so.

deadjim

10/30/19 3:41 PM

Post #53

Re: #52: @stockdawg44 - trading millions and millions of shares today, should

Could go either way. Seen them go another 300% or tank after the first run.

stockdawg44 Free

10/30/19 3:37 PM

Post #52

Re: #51: @deadjim - Why do you think that?

trading millions and millions of shares today, should be at $6+ w the volume, float etc. etc....seen this type of action before several times

deadjim

10/30/19 3:31 PM

Post #51

Re: #50: @stockdawg44 - i still think an offering or diluted shares

Why do you think that?

stockdawg44 Free

10/30/19 3:30 PM

Post #50

Re: #49: @deadjim - She’s strong

i still think an offering or diluted shares hit the market, either way it's been a good trader play.....

deadjim

10/30/19 3:28 PM

Post #49

Re: #48: @stockdawg44 - I flipped a few, easy in/out all day

She’s strong

stockdawg44 Free

10/30/19 3:02 PM

Post #48

Re: #47: @deadjim - I’m surprised how much cash these guys have.

I flipped a few, easy in/out all day long....to me it appears it's trading like an offering or diluting is happening.

The slow rise to new highs, all this volume and the swings .....90 to $3.30+, day 3 of the run.....

my take

deadjim

10/30/19 2:43 PM

Post #47

I’m surprised how much cash these guys have. Was there a raise recently at some point? These are the questions I ask myself because this board is dead

deadjim

10/30/19 2:21 PM

Post #46

Re: #45: @deadjim - I SEE it happening as long as it

There’s the .90s test... If it retest it may have a nice quick flip to the downside but new hires could send it to fours or five

deadjim

10/30/19 2:00 PM

Post #45

Re: #44: @deadjim - can she squeeze to nhods?

I SEE it happening as long as it holds 2.90s.. Do it

deadjim

10/30/19 1:22 PM

Post #44

can she squeeze to nhods?

saj

10/30/19 12:13 PM

Post #43

the Nov 2.5 calls had a nice bump today

swampboots PremiumMember

10/30/19 11:19 AM

Post #42

ISEE 3.03 just keeping track to measure my early odd enthusiasm.

swampboots PremiumMember

10/30/19 10:09 AM

Post #41

ISEE 2.41 sellers rare.

swampboots PremiumMember

10/29/19 7:04 PM

Post #40

Just to be fair this is something to consider at this time of near triple of lows before the news:

DewDiligence Member Level Tuesday, 10/29/19 06:16:22 PM
Re: swampboots post# 226558 0
Post # of 226566

ISEE isn’t getting much respect because it’s the renamed OPHT, whose Fovista failed horrifically in wet AMD (#msg-148256773, #msg-127913009, #msg-127173982, #msg-133812911).

As for Zimura... it, too, was a wet-AMD drug that’s been repurposed for dry AMD (https://www.mdmag.com/medical-news/zimura-lucentis-combo-safe-but-company-decides-not-to-move-forward ); it might work, of course, but I wouldn’t bank on it.

Respond | View Replies (1)

swampboots PremiumMember

10/29/19 4:52 PM

Post #39

Re: #34: @swampboots - ISEE 1.53 to now 1.87, true (honest) supply

ISEE 2,25 HOD only man in universe telling whole story get only part of big big picture. A stock with some cash with only remedy for unmet huge need can only bounce from any price before new data repudiates.....Only few times a decade something like this occurs.

saj

10/29/19 3:52 PM

Post #38

Re: #35: @saj - Remembering when OPHT dropped at the end of

ISEE the price moving up :)

swampboots PremiumMember

10/29/19 2:07 PM

Post #37

And to point out , the ISEE drug showing a positive can be compelling to millions:

“Geographic atrophy involving the center of the macula is arguably the most unmet need in the treatment of macular degeneration. Patients report trouble reading, trouble functioning in dim environments and seeing blind spots or scotomas that slowly enlarge,” notes Dr. Aleksandra Rachitskaya, an ophthalmologist and retina specialist with Cleveland Clinic."

swampboots PremiumMember

10/29/19 1:22 PM

Post #36

Re: #35: @saj - Remembering when OPHT dropped at the end of

You know little of what's big,lol.

saj

10/29/19 1:13 PM

Post #35

Remembering when OPHT dropped at the end of 2016, surprised it hasn't popped higher yet

swampboots PremiumMember

10/29/19 12:49 PM

Post #34

ISEE 1.53 to now 1.87, true (honest) supply and demand now.

swampboots PremiumMember

10/29/19 10:34 AM

Post #33

OT: Yikes :I'm only one on IHUB who can SEE?

swampboots PremiumMember

10/29/19 10:29 AM

Post #32

ISEE :could it be, no predatory schemers painting and scalping?

swampboots PremiumMember

10/29/19 9:20 AM

Post #31

ISEE 1.58 , yet better color:

https://seekingalpha.com/article/4057593-buy-ophthotech-get-cash-zimura-free

swampboots PremiumMember

10/28/19 8:39 PM

Post #30

ISEE more color:
https://www.fiercebiotech.com/biotech/ophthotech-now-iveric-hits-eye-drug-goals-as-shares-jump-for-tiny-biotech

swampboots PremiumMember

10/28/19 3:27 PM

Post #29

ISEE 1.65 again from 1.99, stay back, I'll play alone, as notable Lucentis and Eyelea only treat wet Macular Degeneration, just 15% of all cases, and they have billion dollar drug.

ISEE is huge as only game in town for the victims of this disease.

swampboots PremiumMember

10/28/19 11:28 AM

Post #28

Re: #27: @swampboots - ISEE in a small 1.61 very volatile

ISEE Co: site release:
https://investors.ivericbio.com/news-releases/news-release-details/iveric-bios-zimurar-novel-complement-c5-inhibitor-met-its

swampboots PremiumMember

10/28/19 10:32 AM

Post #27

Re: #26: @swampboots - ISEE: Out 1.89 want 1.60's, to try on

ISEE in a small 1.61 very volatile both ways now.

swampboots PremiumMember

10/28/19 10:27 AM

Post #26

Re: #24: @swampboots - ISEE Doubled:

ISEE: Out 1.89 want 1.60's, to try on this unmet catastrophe they may tame.

Older

Emerging Vision, Inc. (fka ISEE)

Followers	2	Posters	18
Posts (Today)	0	Posts (Total)	75
Created	08/15/06	Type	Free
Moderators

Emerging Vision, Inc., together with its subsidiaries, engages in the operation and franchising of retail optical stores in the United States. It operates its retail optical stores under the trade names Sterling Optical, Site For Sore Eyes, Duling Optical, and Singer Specs. The company’s stores offer eye care products and services, such as prescription and non prescription eyeglasses, eyeglass frames, ophthalmic lenses, contact lenses, sunglasses, and ancillary items. It also operates VisionCare of California, Inc., a health care maintenance organization, which employs licensed optometrists, rendering services in offices located immediately adjacent to, or within, most Sterling Stores located in California. As of May 17, 2006, the company operated 157 franchised and company-owned stores. It operates and franchises retail locations in 15 states, including California, Delaware, Florida, Illinois, Maryland, Massachusetts, Nevada, New Jersey, New York, North Dakota, Pennsylvania, South Dakota, Virginia, Washington D.C., West Virginia, and Wisconsin; Ontario, Canada; and the U.S. Virgin Islands. The company also offers managed vision care under the trade name Insight Managed Vision Care, which provides services or products to a covered participant. Emerging Vision was incorporated in 1992 and is headquartered in Garden City, New York. As of August 14, 06 A/S- 150,000,000 O/S- 70,323,698 Emerging Vision Inc. 100 Quentin Roosevelt Boulevard Suite 508 Garden City, NY 11530 Phone: 516-390-2106 Web Site: http://www.emergingvision.com

Board Info

Posts Today	0
Posts (Total)	75
Posters	18
Moderators

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Emerging Vision, Inc. (fka ISEE)

Emerging Vision, Inc. (fka ISEE)

Join the InvestorsHub Community

Emerging Vision, Inc. (fka ISEE)

Board Info